[caption id="attachment_20476" align="alignright" width="300"] Richard G. Pestell, AO., MD, PhD FACP, FRACP, MBA[/caption]The Baruch S. Blumberg Institute has received a generous gift from Distinguished Professor Richard G. Pestell, AO., MD, PhD FACP, FRACP, MBA.Dr. Pestell assigned the Blumberg Institute
The Baruch S. Blumberg Institute presented the 2025 Lam Excellence in Medicinal and Chemistry Award recently to Dan Nguyen, BS, senior research scientist in medicinal chemistry, Blumberg Institute and Mark E. McDonell, PhD, director of chemistry, Fox Chase
Blumberg Institute faculty presented at the HEP-DART 2025, Dec. 7-11, 2025 in Honolulu, Hawaii. HEP-Dart, an in-person meeting, is designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders.Yanming Du, professor
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) today welcomed NIH Director Jay Bhattacharya, MD, PhD, for a visit highlighting collaborative research, innovation and academic programs advancing public health and biomedical discovery.U.S.
Blumberg Institute Distinguished Professor Richard G. Pestell, MD, PhD FACP, FRACP, MBA, gave presentations recently at two international scientific conferences on a promising potential therapy for metastatic triple-negative breast cancer.The new findings presented at European Society for
Jinhong Chang, MD, PhD, was chosen for her outstanding research in molecular virology and antiviral drug discovery. The Baruch S. Blumberg Institute presented the Harvey J. Alter Chair, a newly created honor, to Jinhong Chang, MD, PhD,
Ju-Tao Guo, MD, globally recognized expert in hepatitis B virology, will lead the Pennsylvania nonprofit research organization.Ju-Tao Guo, MD, a leading expert in hepatitis B virology, was named president of the Baruch S. Blumberg Institute by its
The letter below was sent to U.S. Congressman Guy Reschenthaler and Congresswoman Madeleine Dean on behalf of the Pennsylvania Ad Hoc NIH Funding Advocacy Coalition. A PDF version can be found here. To : Congressman Guy Reschenthaler 2209
Dr. Sofia was responsible for the discovery and early development of sofosbuvir, which became the backbone of many hepatitis C curative therapies.Award-winning scientist Michael J. Sofia, PhD, who discovered the first reliably effective treatment for hepatitis C,
The Hepatitis B Foundation, Baruch S. Blumberg Institute and American Philosophical Society, joined together to celebrate the legacy—and the 100th birthday—of the late Baruch S. Blumberg, MD, DPhil, a Nobel Laureate, on July 29 in Philadelphia.More than
